Related Experiment Video
Updated: May 11, 2026

High-Resolution Fluorespirometry to Assess Dynamic Changes in Mitochondrial Membrane Potential in Human Immune Cells
Published on: May 24, 2024
Mitochondrial ROS in the prohypertensive immune response
Rafal R Nazarewicz1, Sergey I Dikalov
1Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37212, USA. r.nazar@Vanderbilt.edu
Abstract:
In the past decade, it has become clear that reactive oxygen species (ROS) and inflammation play an important role in the development of hypertension. Scavenging of mitochondrial superoxide and blocking either IL-17 or tumor necrosis factor-α (TNF-α) attenuates hypertension. T-cells, critical for development of hypertension, once activated intensively produce cytokines, proliferate, and differentiate. Thus T-cell activation leads to expanded energy demand. To fulfill these needs, T-cells through tightly regulated mechanisms, supported by mitochondrial ROS (mtROS), alter their metabolic phenotype. In this review we summarize data and show evidence supporting new concept that mtROS directly contributes to prohypertensive response of immune cells.
Related Concept Videos
Hypertension II: Pathophysiology
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

